/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

BIOTE CORP Share Price Today: Live Updates & Key Insights

BIOTE CORP share price today is $1.62, up -10.47%. The stock opened at $1.65 against the previous close of $1.72, with an intraday high of $1.77 and low of $1.545.

BIOTE CORP Share Price Chart

style
pb-0

BIOTE CORP

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

BIOTE CORP Share Price Performance

$1.62 -0.1047(-10.47%) BTMD at 13 Mar 2026 12:19 PM Medical Care Facilities
Lowest Today 1.545
Highest Today 1.77
Today’s Open 1.65
Prev. Close 1.72
52 Week High 4.75
52 Week Low 1.54
Day’s Range: Low 1.545 High 1.77
52-Week Range: Low 1.54 High 4.75
1 day return -
1 Week return -17.64
1 month return -28.03
3 month return -41.33
6 month return -55.23
1 year return -50.0
3 year return -68.44
5 year return -
10 year return -

BIOTE CORP Institutional Holdings

325 Capital LLC 14.82

Bandera Partners LLC 7.44

BlackRock Inc 5.68

Vanguard Group Inc 4.71

Vanguard Total Stock Mkt Idx Inv 2.70

Acadian Asset Management LLC 2.26

iShares Russell 2000 ETF 2.22

Geode Capital Management, LLC 2.00

Dimensional Fund Advisors, Inc. 1.85

State Street Corp 1.67

Fidelity Small Cap Index 0.96

GlobeFlex Capital, L.P. 0.89

Northern Trust Corp 0.87

Vanguard Institutional Extnd Mkt Idx Tr 0.81

Rice Hall James & Associates, LLC 0.78

Renaissance Technologies Corp 0.66

Morgan Stanley - Brokerage Accounts 0.60

iShares Russell 2000 Value ETF 0.56

STRS OHIO 0.54

DFA US Small Cap I 0.54

Los Angeles Capital Management LLC 0.48

Perritt Capital Management Inc. 0.46

Vanguard Russell 2000 ETF 0.45

DFA US Micro Cap I 0.43

Fidelity Extended Market Index 0.40

State St Russell Sm Cap® Indx SL Cl I 0.38

Bank of New York Mellon Corp 0.37

Perritt MicroCap Opportunities Investor 0.36

Bridgeway Capital Management, LLC 0.34

Winton Capital Group Ltd 0.34

SSgA Russell Small Cap Completeness Idx 0.33

State St Russell Sm/Mid Cp® Indx SL Cl I 0.33

Jacobs Levy Equity Management, Inc. 0.32

Dimensional US Small Cap ETF 0.30

iShares Russell 2000 Growth ETF 0.29

iShares Micro-Cap ETF 0.27

NT R2000 Index Fund - NL 0.23

Blackrock Extended Mkt Fund CF 0.23

Schwab Small Cap Index 0.21

Extended Equity Market Fund K 0.20

BIOTE CORP Market Status

Strong Buy: 5

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

BIOTE CORP Fundamentals

Market Cap 82.30 M

PB Ratio 2.9604

PE Ratio 2.15

Enterprise Value 131.13 M

Total Assets 107.61 M

Volume 485640

BIOTE CORP Company Financials

Annual Revenue FY23:184142000 184.1M, FY22:164957000 165.0M, FY21:139396000 139.4M, FY20:116568000 116.6M, FY19:109976000 110.0M

Annual Profit FY23:124846000 124.8M, FY22:110382000 110.4M, FY21:90579000 90.6M, FY20:71639000 71.6M, FY19:66411000 66.4M

Annual Net worth FY23:-2796000 -2.8M, FY22:1324000 1.3M, FY21:32619000 32.6M, FY20:29162000 29.2M, FY19:21287000 21.3M

Quarterly Revenue Q3/2025:47956000 48.0M, Q2/2025:48863000 48.9M, Q1/2025:48992000 49.0M, Q3/2024:51384000 51.4M, Q2/2024:49169000 49.2M

Quarterly Profit Q3/2025:34418000 34.4M, Q2/2025:34988000 35.0M, Q1/2025:36382000 36.4M, Q3/2024:36212000 36.2M, Q2/2024:33882000 33.9M

Quarterly Net worth Q3/2025:8188000 8.2M, Q2/2025:3185000 3.2M, Q1/2025:13718000 13.7M, Q3/2024:10702000 10.7M, Q2/2024:-6322000 -6.3M

About BIOTE CORP & investment objective

Company Information biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

Organisation Medical Care Facilities

Employees 217

Industry Medical Care Facilities

CEO Mr. Bret Christensen

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow